Tuesday March 31, 2020

Know About the Similarities and Differences Between the Healthcare System of India and USA

Healthcare: India and US can learn from each other

Healthcare India USA
WHO ranked USA 37 and India 112 for its healthcare systems. Wikimedia Commons


India and the United States of America are the two largest democracies in the world. For most of this 21st century, they have served as solid examples for others to follow. The same cannot be said for their delivery of healthcare. The World Health Organization (WHO) provided its first and only ranking of health systems in 2000. The US ranked 37 and India ranked 112 out of 191 countries.

The current coronavirus crisis, which the WHO declares has the potential of becoming a pandemic illustrates the need for a world-class health care system. Both India and the US have coronavirus cases. India has responded quickly by putting a systemic nation-wide plan in place to combat the virus. The US has responded very slowly as President Donald Trump has politicized the issue, dismissed its importance and even labeled it a “new hoax”.

Although there have been distinctly different responses by the US and India to the coronavirus epidemic and there was a substantial distance between their rankings in both cited studies, there are differences and similarities in the healthcare delivery in these two democracies. More importantly, there are lessons that they can learn from each other to enhance the healthcare delivered to and health of their citizens.

Healthcare India USA
There are many differences between India and the US healthcare systems. Pixabay

There are many differences between India and the US healthcare systems. The primary ones include: the level of expenditure; the nature of healthcare support, and the nature of coverage. According to various reports, the US spends close to 18 per cent of its GDP on healthcare compared to less than just 4 per cent of GDP by India. The average expenditure per capita in the US more than $10,000 in the US and less than $100 in India.

This difference is huge. So, too is the nature of healthcare support. In the US there is broad and extensive quality support through both public and private facilities. In India, the private sector dominates quality healthcare delivery which restricts access for many middle class or poor citizens.

This disparity is heightened by the fact that because a majority of Americans have some form of insurance coverage — only 10 to 12 per cent have to pay for healthcare out of their own pockets. In contrast, around 70 per cent of Indians do not have any health insurance. So, they have to pay out of their own pocket for medical services. In spite of these differences which appear gargantuan, there are some similarities of considerable magnitude in the nature of the healthcare systems as well.

In the US and India alike, there are far too few medical facilities and medical professionals in rural areas. There used to be an adequate supply in the US but they have disappeared over the past few decades. There have never been enough in India in the rural areas where over 66 per cent of the citizens reside.

In both countries, businesses interests, hospitals, medical doctors and other influentials have a substantial impact on health policies. And, the individual states (50 in the US and 28 in India) determine to a great extent the nature of the public health system within their boundaries.

Those who fare most poorly in both the US and India are the poor. In the US, poor adults are five times as likely as those with good incomes to report being in fair or poor health. In India, a recent study found that the poor in the poorer states made higher use of public health services but were still paying higher out of pocket expenses than those in states that were more well off.

Healthcare India USA
In India, the private sector dominates quality healthcare delivery which restricts access for many middle class or poor citizens. Pixabay

These similarities and differences highlight potential areas to address to improve the healthcare delivery in both countries. And, even though neither the US nor India are at the top of the list, they still have positive healthcare lessons they can teach each other.

From America for India, there is Medicare and the Affordable Care Act (ACA). Medicare was signed into law in 1965 primarily to provide health insurance to adults 65 years and older to ensure they had access to quality healthcare as they aged. In 2018, it covered more than 52 million Americans.

The Affordable Care Act was signed into law by President Barack Obama in 2010. Its intent was to ensure access to quality healthcare for all Americans by providing affordable healthcare insurance coverage to over 55 million uninsured individuals. For a variety of reasons, the ACA has not rolled out as planned and it is threatened by the Trump administration. Nonetheless, it is estimated that it has added close to 20 million to the insurance rolls since its implementation.

From India for America, there is innovation and cost control. In 2018, Dartmouth professor Vijay Govindarajan and Northeaster University professor Ravi Ramamurti published a book, ‘Reverse Innovation in Health Care: How to Make Value Based Delivery Work’. Their book is based upon visiting over two dozen hospitals in India and interviewing more than 125 health care executives in India and the US. In an article on their book they state, “We learned that some of the most proactive hospitals in the West are adopting world-class innovations of Indian healthcare institutions in order to boost quality, lower costs, and expand access to the underserved”

India and the US can learn from each other. They can also learn by looking at best practices in healthcare around the world. The rankings show that both of these democracies have much room for improvement in healthcare.

In 2018, the Modi administration launched its Ayushman Bharat scheme to provide a comprehensive form of insurance coverage to the approximately 300 million Indians living in poverty and those in rural areas. This was an important step forward.

The budget for this fiscal year announced on February 1 advances that step by allocating funds to establish more hospitals in Tier II and Tier III cities. The budget also proposes to address the shortage of medical professionals throughout the country by converting existing hospitals to medical colleges and implementing a “special bridge course” for the development of general physicians and specialists.

Also Read- Actress Anushka Sharma: I was Allowed to do Whatever I Wanted

These are moves in the right direction. India should carry on with them and other efforts and new initiatives to make its health care system one of the finest in the world. The US should do the same. This must be the case because in the final analysis, a healthy democracy depends on the health of its people. If they are cared for, they will care for their country and the democracy will thrive. (IANS)

Next Story

Can TB Vaccine Fight COVID-19? Here is the Answer

TB vaccine a potential new tool to fight COVID-19: Study

Researchers have found that Bacillus Calmette-Guerin (BCG), a vaccine for tuberculosis (TB), could be a potential new tool in the fight against the disease. Pixabay

Examining how the COVID-19 has impacted different countries, researchers have found that Bacillus Calmette-Guerin (BCG), a vaccine for tuberculosis (TB), could be a potential new tool in the fight against the disease.

The study that appeared in the pre-print repository medRxiv, proposed that national differences in COVID-19 impact could be partially explained by the different national policies respect to BCG childhood vaccination.

The BCG vaccine has existed for almost a century and is one of the most widely used of all current vaccines.

Please follow NewsGram on Twitter to get updates on the latest news

BCG vaccine has a documented protective effect against meningitis and disseminated TB in children.

The BCG vaccine has existed for almost a century and is one of the most widely used of all current vaccines. Pixabay

It has also been reported to offer broad protection to respiratory infections.

For the study, the researchers compared large number of countries BCG vaccination policies with the morbidity and mortality for COVID-19.

“We found that countries without universal policies of BCG vaccination (Italy, the Netherlands, the US) have been more severely affected compared to countries with universal and long-standing BCG policies,” said the study conducted by researchers from New York Institute of Technology (NYIT) College of Osteopathic Medicine in the US.

The number of confirmed coronavirus cases in the US has increased to 142,502, the highest in terms of infections globally, according to the latest tally from Johns Hopkins University’s Center for Systems Science and Engineering (CSSE).

The CSSE data showed that at least 34,026 people have died due to the disease in the country.

In Italy, which is one of the worst affected countries, 10,779 people have died due to COVID-19.

In this latest study on impact of BCG vaccination on COVID-19, researchers also found that countries that have a late start of universal BCG policy, for example, Iran had high mortality, consistent with the idea that BCG protects the vaccinated elderly population.

“There was a positive significant correlation between the year of the establishment of universal BCG vaccination and the mortality rate, consistent with the idea that the earlier that a policy was established, the larger fraction of the elderly population would be protected,” said the study.

BCG vaccine has a documented protective effect against meningitis and disseminated TB in children. Pixabay

“For instance, Iran has a current universal BCG vaccination policy but it just started in 1984, and has an elevated mortality with 19.7 deaths per million inhabitants.

“In contrast, Japan started its universal BCG policy in 1947 and has around 100 times less deaths per million people, with 0.28 deaths. Brazil started universal vaccination in 1920 and also has an even lower mortality rate of 0.0573 deaths per million inhabitants,” the resulst showed.

Iran announced 2,901 new COVID-19 cases on Sunday as the total number of confirmed cases soared to 38,309. Also, the death toll from the disease reached 2,640 in Iran, while 12,391 patients have recovered.

Please follow NewsGram on Facebook to get updates on the latest news

As the numbers of tuberculosis cases dropped in the late 20th century, several middle high and high-income countries in Europe dropped the universal BCG policy between years 1963 and 2010.

“The combination of reduced morbidity and mortality makes BCG vaccination a potential new tool in the fight against COVID-19,” the researchers concluded.

Also Read- Taking Care of Finances Amid Coronavirus Crisis

Gonzalo H. Otazu of NYIT is the corresponding author of the study.

The COVID-19 death toll in Europe climbed to over 21,000 out of more than 360,000 confirmed cases. (IANS)